Postpartum and contraception in women after gestational diabetes
Gespeichert in:
| Titel: | Postpartum and contraception in women after gestational diabetes |
|---|---|
| Autoren: | Kerlan, Véronique |
| Weitere Verfasser: | Calvez, Ghislaine, Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO), Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO), Service d'Endocrinologie (CHRU - Endocrino), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest) |
| Quelle: | Diabetes & Metabolism. 36:566-574 |
| Verlagsinformationen: | Elsevier BV, 2010. |
| Publikationsjahr: | 2010 |
| Schlagwörter: | MESH: Contraception, Adult, MESH: Humans, [SDV]Life Sciences [q-bio], Postpartum Period, MESH: Adult, 3. Good health, MESH: Postpartum Period, [SDV] Life Sciences [q-bio], Diabetes, Gestational, 03 medical and health sciences, MESH: Diabetes, MESH: Pregnancy, Breast Feeding, Contraception, 0302 clinical medicine, Pregnancy, MESH: Breast Feeding, MESH: Child, Gestational, Humans, Female, Child, MESH: Female |
| Beschreibung: | Women who have had gestational diabetes mellitus must be monitored in the immediate postpartum period to ensure that blood glucose levels return to normal without further treatment. In the few studies performed specifically in these women, those that breastfed did not have a different metabolic profile, at least during the period of breastfeeding; the metabolic profiles of children born to women that had gestational diabetes and that breastfed also did not differ from those that were not breastfed. The choice of contraception must mainly take into consideration the associated risk factors. The studies, even if few have specifically focused on women with a history of gestational diabetes, have not demonstrated a significant disturbance of glucose metabolism while using hormonal contraception, whether combined oral oestrogen/progestogen or progestogen-only contraception. However, the presence of obesity, hypertension, or dyslipidaemia must direct the choice of contraception towards one without cardiovascular consequences. In these cases, the intrauterine device is an excellent choice. |
| Publikationsart: | Article |
| Sprache: | English |
| ISSN: | 1262-3636 |
| DOI: | 10.1016/j.diabet.2010.11.009 |
| Zugangs-URL: | https://pubmed.ncbi.nlm.nih.gov/21163421 https://www.sciencedirect.com/science/article/pii/S1262363610002740 http://europepmc.org/abstract/MED/21163421 http://www.ncbi.nlm.nih.gov/pubmed/21163421/ |
| Rights: | Elsevier TDM |
| Dokumentencode: | edsair.doi.dedup.....b7605af5cd79f6548b2d9da03210b465 |
| Datenbank: | OpenAIRE |
Full Text Finder 
Nájsť tento článok vo Web of Science | Abstract: | Women who have had gestational diabetes mellitus must be monitored in the immediate postpartum period to ensure that blood glucose levels return to normal without further treatment. In the few studies performed specifically in these women, those that breastfed did not have a different metabolic profile, at least during the period of breastfeeding; the metabolic profiles of children born to women that had gestational diabetes and that breastfed also did not differ from those that were not breastfed. The choice of contraception must mainly take into consideration the associated risk factors. The studies, even if few have specifically focused on women with a history of gestational diabetes, have not demonstrated a significant disturbance of glucose metabolism while using hormonal contraception, whether combined oral oestrogen/progestogen or progestogen-only contraception. However, the presence of obesity, hypertension, or dyslipidaemia must direct the choice of contraception towards one without cardiovascular consequences. In these cases, the intrauterine device is an excellent choice. |
|---|---|
| ISSN: | 12623636 |
| DOI: | 10.1016/j.diabet.2010.11.009 |